Sustained tetracycline-regulated transgene expression in vivo in rat retinal ganglion cells using a single type 2 adeno-associated viral vector

Journal of Gene Medicine

Volumn 5, Issue 6, 2003, Pages 493-501

  Folliot, Sebastien ^a   Briot, Delphine ^a   Conrath, Hervé ^a   Provost, Nathalie ^a   Cherel, Yan ^b   Moullier, Philippe ^a   Rolling, Fabienne ^a  

^a HÔTEL DIEU   (France)

^b LUNAM UNIVERSITÉ   (France)

Author keywords

Ganglion cells; Gene regulation; Gene transfer; Retina; Tetracycline

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; COMPLEMENTARY DNA; DOXYCYCLINE; ECDYSONE; ERYTHROPOIETIN; FIBROBLAST GROWTH FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEIN; MIFEPRISTONE; PARVOVIRUS VECTOR; RAPAMYCIN; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TRANSACTIVATOR PROTEIN; PHOTOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FLUORESCENCE; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; GLAUCOMA; HISTOLOGY; IN VIVO STUDY; MONITORING; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; RAT STRAIN; REPORTER GENE; RETINA DEGENERATION; RETINA GANGLION CELL; RETINITIS PIGMENTOSA; SIGNAL TRANSDUCTION; TRANSGENE; VIRAL GENE THERAPY; VIRUS RECOMBINANT; ADENO ASSOCIATED VIRUS; ANIMAL; DRUG EFFECT; GENE THERAPY; GENE VECTOR; GENETICS; METABOLISM; PLANT GROWTH; TRANSACTIVATION; ULTRASTRUCTURE;

ANIMALS; DEPENDOVIRUS; DOXYCYCLINE; GENE EXPRESSION REGULATION, VIRAL; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; LUMINESCENT PROTEINS; RATS; RETINAL GANGLION CELLS; TETRACYCLINE; TRANS-ACTIVATION (GENETICS); TRANSGENES; TROPISM;

EID: 1542437242     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.367     Document Type: Article

References (43)

1. Zolotukhin S, Potter M, Hauswirth WW, et al. A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol 1996; 70: 4646-4654.
2. Bennett J, Duan D, Engelhardt JF, et al. Real-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction. Invest Ophthalmol Vis Sci 1997; 38: 2857-2863.
3. Bennett J, Maguire AM, Cideciyan AV, et al. Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl Acad Sci U S A 1999; 96: 9920-9925.
4. Dudus L, Anand V, Acland GM, et al. Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV. Vision Res 1999; 39: 2545-2553.
5. Ali RR, Reichel MB, Thrasher AJ, et al. Gene transfer into the mouse retina mediated by an adeno-associated viral vector. Hum Mol Genet 1996; 5: 591-594.
6. Ali RR, Reichel MB, De Alwis M, et al. Adeno-associated virus gene transfer to mouse retina. Hum Gene Ther 1998; 9: 81-86.
7. Flannery JG, Zolotukhin S, Vaguero MI, et al. Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc Natl Acad Sci U S A 1997; 94: 6916-6921.
8. Rolling F, Shen WY, Tabarias H, et al. Evaluation of adeno-associated virus-mediated gene transfer into the rat retina by clinical fluorescence photography. Hum Gene Ther 1999; 10: 641-648.
9. Rabinowitz JE, Rolling F, Li C, et al. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 2002; 76: 791-801.
10. Acland GM, Aguirre GD, Ray J, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet 2001; 28: 92-95.
11. Ali RR, Sarra GM, Stephens C, et al. Restoration of photo-receptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat Genet 2000; 25: 306-310.
12. Phelan JK, Bok D. A brief review of retinitis pigmentosa and the identified retinitis pigmentosa genes. Mol Vis 2000; 6: 116-124.
13. Liang FQ, Aleman TS, Dejneka NS, et al. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa. Mol Ther 2001; 4: 461-472.
14. Lau D, McGee LH, Zhou S, et al. Retinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2. Invest Ophthalmol Vis Sci 2000; 41: 3622-3633.
15. Green ES, Rendahl KG, Zhou S, et al. Two animal models of retinal degeneration are rescued by recombinant adeno-associated virus-mediated production of fgf-5 and fgf-18. Mol Ther 2001; 3 507-515.
16. McGee Sanftner LH, Abel H, Hauswirth WW, et al. Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa. Mol Ther 2001; 4: 622-629.
17. Rivera VM, Clackson T, Natesan S, et al. A humanized system for pharmacologic control of gene expression. Nat Med 1996; 2: 1028-1032.
18. Ye X, Rivera VM, Zoltick P, et al. Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science 1999; 283: 88-91.
19. Serguera C, Bohl D, Rolland E, et al. Control of erythropoietin secretion by doxycycline or mifepristone in mice bearing polymer-encapsulated engineered cells. Hum Gene Ther 1999; 10 375-383.
20. No D, Yao TP, Evans RM. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci U S A 1996; 93: 3346-3351.
21. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracyclin-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547-5551.
22. Gossen M, Freundlieb S, Bender G, et al. Transcriptional activation by tetracyclines in mammalian cells. Science 1995; 268: 1766-1769.
23. Auricchio A, Rivera V, Clackson T, et al. Pharmacological regulation of protein expression from adeno-associated viral vectors in the eye. Mol Ther 2002; 6: 238.
24. Bohl D, Naffakh N, Heard J-M. Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts. Nature Med 1997; 3: 299-305.
25. Bohl D, Salvetti A, Moullier P, et al. Control of erythropoietin delivery by doxycyclin in mice after intramuscular injection of adeno-associated vector. Blood 1998; 92: 1512-1517.
26. Favre D, Blouin V, Provost N, et al. Lack of immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus. J Virol 2002; 76: 11605-11611.
27. McGee Sanftner LH, Rendahl KG, Quiroz D, et al. Recombinant aav-mediated delivery of a tet-inducible reporter gene to the rat retina. Mol Ther 2001; 3: 688-696.
28. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991; 108: 193-199.
29. Samulski RJ, Chang LS, Shenk T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol 1989; 63: 3822-3828.
30. Grimm D, Kern A, Rittner K, et al. Novel tools for production and purification of recombinant adeno-associated virus vectors. Hum Gene Ther 1998; 9: 2745-2760.
31. Zolotukhin S, Byrne B J, Mason E, et al. Recombinant adeno-associated virus purification using novel methods improves infections titer and yield. Gene Ther 1999; 6: 973-985.
32. Salvetti A, Orève S, Chadeuf G, et al. Factors influencing recombinant adeno-associated virus production. Hum Gene Ther 1998; 9: 695-706.
33. Duisit G, Conrath H, Saleun S, et al. Five recombinant simian immunodeficiency virus (SIV) pseudotypes lead to exclusive transduction of retinal pigmented epithelium in rat. Mol Ther 2002; 6: 446-454.
34. Urlinger S, Baron U, Thellmann M, et al. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci U S A 2000; 97: 7963-7968.
35. Dejneka NS, Auricchio A, Maguire AM, et al. Pharmacologically regulated gene expression in the retina following transduction with viral vectors. Gene Ther 2001; 8: 442-446.
36. Guy J, Qi X, Muzyczka N, et al. Reporter expression persists 1 year after adeno-associated virus-mediated gene transfer to the optic nerve. Arch Ophthalmol 1999; 117: 929-937.
37. Fitzsimons HL, McKenzie JM, During MJ. Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain. Gene Ther 2001; 8: 1675-1681.
38. Freundlieb S, Schirra-Muller C, Bujard H. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. J Gene Med 1999; 1: 4-12.
39. Smith-Arica JR, Williams JC, Stone D, et al. Switching on and off transgene expression within lactotrophic cells in the anterior pituitary gland in vivo. Endocrinology 2001; 142: 2521-2532.
40. Smith-Arica JR, Morelli AE, Larregina AT, et al. Cell-type-specific and regulatable transgenesis in the adult brain: adenovirus-encoded combined transcriptional targeting and inducible transgene expression. Mol Ther 2000; 2: 579-587.
41. Hamel CP, Jenkins NA, Gilbert DJ, et al. The gene for the retinal pigment epithelium-specific protein RPE65 is localized to human lp31 and mouse 3. Genomics 1994; 20: 509-512.
42. Gal A, Li Y, Thompson DA, et al. Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa. Nat Genet 2000; 26: 270-271.
43. McKinnon SJ, Lehman DM, Tahzib NG, et al. Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model. Mol Ther 2002; 5: 780-787.